| Three Months Ended September 30, | ||||||||
| 2024 | 2023 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (804,787) | $ | (5,472,568) | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Share-based compensation | 26,736 | 132,739 | ||||||
| Depreciation and amortization expense | 165,713 | 165,909 | ||||||
| Non-cash rent expense | 19,528 | 36,166 | ||||||
| Change in fair value of accompanying warrant liability | (2,966,245) | - | ||||||
| Change in fair value of contingent consideration | 91,551 | 124,558 | ||||||
| Effect of foreign currency remeasurement | 233,044 | 67,319 | ||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable, non-trade | 10,924 | (16,252) | ||||||
| Prepaid insurance expense | 227,657 | 427,316 | ||||||
| Accounts payable | (917,668) | 880,613 | ||||||
| Accrued expenses and other current liabilities | (367,583) | (704,745) | ||||||
| Operating lease liabilities | (20,268) | (36,393) | ||||||
| Deferred tax liability | (132,216) | (34,793) | ||||||
| Other non-current liabilities | 551 | 331 | ||||||
| Net cash used in operating activities | (4,433,063) | (4,429,800) | ||||||
| Cash flows from financing activities: | ||||||||
| Issue costs associated with ADS shares and ADS pre-funded warrants | (227,747) | - | ||||||
| Proceeds from the exercise of pre-funded ADS warrants | 409 | - | ||||||
| Proceeds from the sale of ADS shares, net | - | 6,261,514 | ||||||
| Stock issued pursuant to a subscription receivable | - | (5,648,976) | ||||||
| Net cash (used in) provided by financing activities | (227,338) | 612,538 | ||||||
| Effect of exchange rate on changes on cash, cash equivalents, and restricted cash | 138,367 | (152,773) | ||||||
| Net decrease in cash, cash equivalents, and restricted cash | (4,660,401) | (3,817,262) | ||||||
| Cash, cash equivalents, and restricted cash, beginning of period | 12,686,935 | 12,181,944 | ||||||
| Cash, cash equivalents, and restricted cash, end of period | $ | 8,164,901 | $ | 8,211,909 | ||||
| Reconciliation of cash, cash equivalents, and restricted cash: | ||||||||
| Cash and cash equivalents | $ | 8,082,410 | $ | 8,135,059 | ||||
| Restricted cash | 82,491 | 76,850 | ||||||
| Total cash, cash equivalents, and restricted cash | $ | 8,164,901 | $ | 8,211,909 | ||||
| Contingent Consideration in a Business Combination | Freestanding Financial Instruments Accompanying Warrants Liability | |||||||
| Balance at June 30, 2024 | $ | 587,762 | $ | 4,657,832 | ||||
| Change in fair value | 91,551 | (2,966,245) | ||||||
| Balance at September 30, 2024 | $ | 679,313 | $ | 1,691,587 | ||||
| Fiscal Three months ended September 30, | ||||||||
| 2024 | 2023 | |||||||
| Net cash used in operating activities | $ | (4,433,063) | $ | (4,429,800) | ||||
| Net cash (used in) provided by financing activities | (227,338) | 612,538 | ||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | $ | (4,660,401) | $ | (3,817,262) | ||||
| September 30, 2024 | ||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Liabilities: | ||||||||||||||||
| Contingent consideration | $ | - | $ | - | $ | 679,313 | $ | 679,313 | ||||||||
| Accompanying warrants liability | - | - | 1,691,587 | 1,691,587 | ||||||||||||
| Total liabilities measured at fair value | $ | - | $ | - | $ | 2,370,900 | $ | 2,370,900 | ||||||||
| Stock | Additional | Accumulated Other | Total | |||||||||||||||||||||||||
| Ordinary Shares | Subscription | Paid-In | Comprehensive | Accumulated | Shareholders' | |||||||||||||||||||||||
| Shares | Amount | Receivable | Capital | Loss | Deficit | Equity | ||||||||||||||||||||||
| Balance at June 30, 2024 | 2,384,539,964 | $ | - | $ | - | $ | 198,481,038 | $ | (3,013,595) | $ | (177,977,071) | $ | 17,490,372 | |||||||||||||||
| Exercise of pre-funded ADS warrants | 733,122,900 | - | - | 409 | - | - | 409 | |||||||||||||||||||||
| Share issue costs | - | - | - | (227,747) | - | - | (227,747) | |||||||||||||||||||||
| Share-based compensation | - | - | - | 26,736 | - | - | 26,736 | |||||||||||||||||||||
| Other comprehensive income | - | - | - | - | 585,381 | - | 585,381 | |||||||||||||||||||||
| Net loss | - | - | - | - | - | (804,787) | (804,787) | |||||||||||||||||||||
| Balance at September 30, 2024 | 3,117,662,864 | $ | - | $ | - | $ | 198,280,436 | $ | (2,428,214) | $ | (178,781,858) | $ | 17,070,364 | |||||||||||||||
| Balance at June 30, 2023 | 1,468,735,424 | $ | - | $ | - | $ | 187,554,251 | $ | (3,058,783) | $ | (162,484,905) | $ | 22,010,563 | |||||||||||||||
| Issuance of ADS shares, net of issuance costs of $0.5 million | 378,155,880 | - | (5,648,976) | 6,261,514 | - | - | 612,538 | |||||||||||||||||||||
| Share-based compensation | - | - | - | 140,448 | - | - | 140,448 | |||||||||||||||||||||
| Other comprehensive loss | - | - | - | - | (63,469) | - | (63,469) | |||||||||||||||||||||
| Net loss | - | - | - | - | - | (5,472,568) | (5,472,568) | |||||||||||||||||||||
| Balance at September 30, 2023 | 1,846,891,304 | $ | - | $ | (5,648,976) | $ | 193,956,213 | $ | (3,122,252) | $ | (167,957,473) | $ | 17,227,512 | |||||||||||||||
